Cargando…
Correction: Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype
Autores principales: | Dong, Xiaoqun, Lin, Qiushi, Aihara, Arihiro, Li, Yu, Huang, Chiung-Kuei, Chung, Waihong, Tang, Qi, Chen, Xuesong, Carlson, Rolf, Nadolny, Christina, Gabriel, Gregory, Olsen, Mark, Wands, Jack R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859923/ https://www.ncbi.nlm.nih.gov/pubmed/31762945 http://dx.doi.org/10.18632/oncotarget.27315 |
Ejemplares similares
-
Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype
por: Dong, Xiaoqun, et al.
Publicado: (2014) -
Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression
por: Huang, Chiung-Kuei, et al.
Publicado: (2016) -
Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway
por: Ogawa, Kosuke, et al.
Publicado: (2019) -
Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases
por: Chung, Waihong, et al.
Publicado: (2020) -
Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas
por: Sturla, Lisa-Marie, et al.
Publicado: (2016)